MYX 3.29% $4.40 mayne pharma group limited

Ann: 2024 Half Year Investor Presentation, page-19

  1. 351 Posts.
    lightbulb Created with Sketch. 201
    Also agree P31,with regards to buyback.
    As long as the sales are growing the buyback is safe.
    If something hits a speed bump in relation to growth....the buyback may be scaled back.

    The canary in the coalmine for me is two fold,
    - 1st virburnum staying on the registry
    - 2 if the buyback is paired back or halted.....we will know the numbers aren't building quickly enough (ie lower revenue,..hence profit)
    These are my two cue's to review my position/ exit.

    AIMHO
    Last edited by flyer100: 26/02/24
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.40
Change
0.140(3.29%)
Mkt cap ! $374.3M
Open High Low Value Volume
$4.25 $4.43 $4.25 $618.9K 141.5K

Buyers (Bids)

No. Vol. Price($)
10 2957 $4.40
 

Sellers (Offers)

Price($) Vol. No.
$4.41 968 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.